Greater Philadelphia was well represented at the Cell & Gene Meeting on the Mesa, held October 11-13, 2022, in Carlsbad, California, and organized by the Alliance for Regenerative Medicine. The hybrid conference featured presentations by leading public and private companies highlighting technical and clinical achievements over the past year in cell therapy, gene therapy, tissue engineering, and broader regenerative medicine technologies.

More than 2,100 attendees participated in the annual conference, which gathers senior executives and top decision-makers to advance cutting-edge research into cures. Among the Greater Philadelphia companies that participated were AmeriSourceBergen, Cabaletta Bio, Carisma Therapeutics, Center […]

Greater Philadelphia’s life sciences ecosystem was recognized with the #5 spot in JLL’s 2022 Life Sciences Research Outlook & Cluster Rankings. The new ranking reflects a rise from the #9 spot in 2021. JLL evaluated geographic clusters on talent (35% weight), funding (30% weight), and commercial real estate (35% weight). Among the highlights was JLL’s recognition of Philadelphia as “home to a deep and growing pool of talent coming from the region’s strong universities.” The report also recognized Philadelphia as a leader in the cell and gene therapy sector.

“We are thrilled to see Philadelphia grow from […]

Iovance Biotherapeutics’ Cell Therapy Center (iCTC) in Greater Philadelphia is the first centralized and scalable manufacturing facility dedicated to producing tumor infiltrating lymphocytes (TIL) as a potential therapy for patients with solid tumor cancers. One of the leaders on the ground at Iovance’s manufacturing facility is Margot Wilson, Director of Operational Excellence. Wilson works to ensure that these TIL cells are properly manufactured to be returned and administered as potential cancer treatments to patients. Wilson’s goal in working at Iovance? To deliver hope to patients who need new options.

Once partnered with a […]

Featured speakers included the CEO Council’s very own Claire Greenwood and Michele Washko, along with PIDC’s Kate McNamara and IPS’s Janine Squire, who shared updates on the growth of the industry.

The publication, which reports on corporate real estate strategies and economic development, has an audience of 48,000 subscribers, including 4,400 who represent biotech and pharmaceutical manufacturers.

An advisory group of regional life sciences and health care leaders is lending its expertise to the PHLCVB as the region addresses the challenges of the COVID-19 crisis on the meetings and conventions industry and tourism.

According to the recently released Q4 2019 Healthcare MoneyTree™ Report, the Biotechnology subsector led the Healthcare industry in the fourth quarter in terms of dollars invested, raising $2.4 billion.